The NIH is investing millions to reduce animal testing, funding AI, computer models, and lab-grown human tissue as ...

Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...

The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...

In his first two years on the job, Health and Human Services Secretary Robert F. Kennedy Jr. has become a polarizing figure ...

The National Association for Biomedical Research said that "there is currently no full replacement for animal models in biomedical research and drug development." (iStock / Getty Images Plus) The FDA ...

The National Institutes of Health announced last week that it will no longer issue funding calls for grant proposals that rely solely on animal testing. Moving forward, all such calls must also ...

Please provide your email address to receive an email when new articles are posted on . The FDA has pledged to reduce animal testing for monoclonal antibodies. The decision reflects longstanding ...

The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...

In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...